BioSpace Collaborative

Academic/Biomedical Research
News & Jobs
Biotechnology and Pharmaceutical Channel Medical Device and Diagnostics Channel Clinical Research Channel BioSpace Collaborative    Job Seekers:  Register | Login          Employers:  Register | Login  

NEWSLETTERS
Free Newsletters
Archive
My Subscriptions

NEWS
News by Subject
News by Disease
News by Date
PLoS
Search News
Post Your News
JoVE

CAREER NETWORK
Job Seeker Login
Most Recent Jobs
Search Jobs
Post Resume
Career Fairs
Career Resources
For Employers

HOTBEDS
Regional News
US & Canada
  Biotech Bay
  Biotech Beach
  Genetown
  Pharm Country
  BioCapital
  BioMidwest
  Bio NC
  BioForest
  Southern Pharm
  BioCanada East
  US Device
Europe
Asia

DIVERSITY

PROFILES
Company Profiles

INTELLIGENCE
Research Store

INDUSTRY EVENTS
Research Events
Post an Event
RESOURCES
Real Estate
Business Opportunities

By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search
 Company Profile

 

Genticel 

Prologue-Biotech
Rue Pierre et Marie Curie BP 28262
Cedex  Labège-Innopole  31682  France
Phone: 33-5-6128-7060 Fax: 33-5-6128-7069


SEARCH JOBS










 Company News
Genticel Reaches An Important Milestone By Launching Its Phase II Trial In Women Infected With High-Risk HPV Before The Appearance Of High Grade Cervical Lesions 3/4/2014 11:11:06 AM    More...
Genticel Appoints Dr Gerald Moeller as Vice-President of Its Supervisory Board 11/7/2013 9:13:20 AM    More...
Genticel Secures $23.7 Million in Capital Funding 4/24/2013 7:24:07 AM    More...
Genticel Announces Positive Data From Its Phase I Trial in Women Infected With High-Risk HPV Before Appearance of Cervical Lesions 10/18/2012 1:05:44 PM    More...
Genticel Completed Recruitment for Its Phase Ib Vaccine Trial in Women Infected With High-risk HPV 2/21/2012 9:28:38 AM    More...
Genticel Has Completed Recruitment of Patients for its Phase I Trial With Procervix, its Therapeutic Vaccine Against Human Papillomavirus (HPV) Types 16 and 18 10/19/2011 11:36:14 AM    More...
Genticel Names Dr Didier Hoch, Former President of Sanofi Pasteur (SASY.PA) MSD, to its Supervisory Board 7/6/2011 1:05:14 PM    More...
Genticel’s Therapeutic Vaccine, Procervix, Aimed At Preventing Cervical Cancer In Patients Already Infected By Human Papillomavirus (HPV), Receives Clearance To Start A Phase I Clinical Trial 7/23/2010 11:21:28 AM    More...
BT PHARMA Secures USD 17.7 Million in Capital Funding and Changes its Name to Genticel 3/9/2010 10:07:28 AM    More...